Saturday, October 3, 2026

GBP/EUR Bearish Momentum: 0.99% Down In The Last 10 Sessions

ViaNews Editorial Team

September 19, 2023

GBP/EUR Bearish Momentum: 0.99% Down In The Last 10 Sessions

(VIANEWS) - GBP/EUR (GBPEUR) has been up by 0.99% for the last 10 sessions. At 14:08 EST on Tuesday, 19 September, GBP/EUR (GBPEUR) is $1.16.

GBP/EUR's yearly highs and lows, it's 7.288% up from its 52-week low and 1.444% down from its 52-week high.

Volatility

GBP/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.09%, a negative 0.06%, and a positive 0.25%, respectively.

GBP/EUR's highest amplitude of average volatility was 0.25% (last week), 0.21% (last month), and 0.25% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GBP/EUR's Forex is considered to be overbought (>=80).

News about

  • Eur/usd bumping towards 1.07 in Monday bullish bounce. According to FXStreet on Monday, 18 September, "Euro bulls will be looking to mark in a green week after the EUR/USD pair has closed bearish for the past nine consecutive weeks, and daily candlesticks have the pair firmly on the downside.", "It's going to be a Dollar-dominant week for the EUR/USD with the economic calendar notably thin for the European Union (EU) side of the equation, and the Federal Reserve (Fed) slated for another rate call in the midweek."
  • According to FXStreet on Monday, 18 September, "The Euro (EUR) alternates ups and downsagainst the US Dollar (USD) at the beginning of the week, prompting EUR/USD to trade around the 1.0660 region following the opening bellin the European markets on Monday.", "As long as the EUR/USD is below the 200-day SMA, the pair might continue to fall."
  • Eur/usd: good demand will emerge near the 1.05 level – ING. According to FXStreet on Monday, 18 September, "Expect EUR/USD to trade on the soft side now that the ECB has told us that rates have peaked. ", "We are sticking with our call that EUR/USD will be trading above 1.10 by year-end."
  • Eur/usd price analysis: reverses recent gains to near 1.0680, eurozone final CPI eyed. According to FXStreet on Tuesday, 19 September, "However, traders of the EUR/USD pair will likely observe the 14-day Relative Strength Index (RSI), which indicates bearish momentum in the short term as it lies below the 50 level.", "The immediate support for the EUR/USD pair appears around the 1.0650 psychological level, followed by the previous week's low at 1.0631."

More news about GBP/EUR (GBPEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com